Nemaura Medical Inc. Quarterly Debt-to-equity in % from Q4 2018 to Q4 2023

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Nemaura Medical Inc. quarterly Debt-to-equity history and growth rate from Q4 2018 to Q4 2023.
Nemaura Medical Inc. Debt-to-equity for the quarter ending December 31, 2023 was -162 %, a 61.6% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q4 2023	-162	+260	+61.6%	Dec 31, 2023
Q3 2023	-186	+679	+78.5%	Sep 30, 2023
Q2 2023	-216	-5.17K	-104%	Jun 30, 2023
Q1 2023	-284	-1.03K	-138%	Mar 31, 2023
Q4 2022	-422	-919	-185%	Dec 31, 2022
Q3 2022	-866	-1.15K	-401%	Sep 30, 2022
Q2 2022	4.95K	+4.77K	+2630%	Jun 30, 2022
Q1 2022	742	+592	+393%	Mar 31, 2022
Q4 2021	497	+390	+366%	Dec 31, 2021
Q3 2021	287	+126	+78.6%	Sep 30, 2021
Q2 2021	182	-2.18K	-92.3%	Jun 30, 2021
Q1 2021	151	+23.8K		Mar 31, 2021
Q4 2020	107	-183	-63.1%	Dec 31, 2020
Q3 2020	161	+11.3	+7.57%	Sep 30, 2020
Q2 2020	2.36K	+2.25K	+1939%	Jun 30, 2020
Q1 2020	-23.6K	-23.7K	-25215%	Mar 31, 2020
Q4 2019	289	+212	+277%	Dec 31, 2019
Q3 2019	150			Sep 30, 2019
Q2 2019	116			Jun 30, 2019
Q1 2019	94.1			Mar 31, 2019
Q4 2018	76.6			Dec 31, 2018

* An asterisk sign (*) next to the value indicates that the value is likely invalid.